RNU6-1089P

Across TCGA pan-cancer cohorts, RNU6-1089P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-1089P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-1089P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-1089P is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and KICH are the cancer types where RNU6-1089P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-1089P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.094	.002	5	view →
KIRP	Male	All	−0.103	.038	2	view →
KICH	All	All	−0.128	.043	1	view →
THCA	Female	All	−0.106	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNU6-1089P–KIRC

Open the KIRC breakdown →